| TAH Drug Code | OKCIT |
|---|---|
| Indications | Prevention of uric acid nephrolithiasis; prevention of Ca renal stones in patients with hypocitraturia; avoidance of the complication of Ca stone formation in uric lithiasis. |
| Dosing | 5 gm dissolved in water QD-QID; adjust dose to urinary pH. (Target urinary pH: 6.5-7.4) |
| Hepatic Impairment | Dose adjustment not necessary |
| Renal Impairment | Dose adjustment not necessary |
| Contraindications | Hyperkalemia, peptic ulcer, abnormal renal function, anuria. |
| Adverse Effects | Abdominal pain; dyspepsia; gastroenteritis; hyperkinesia; nervousness. |
| Pregnancy | Unknown |
| Lactation | Unknown |
| More Info | UpToDate |